Terminal effector Tregs in metastatic lymph nodes of lung cancer patients
I. Kwiecien (Warszawa, Poland), E. Rutkowska (Warszawa, Poland), A. Raniszewska (Warszawa, Poland), J. Bednarek (Warszawa, Poland), R. Sokolowski (Warszawa, Poland), P. Rzepecki (Warszawa, Poland), J. Domagala-Kulawik (Warszawa, Poland)
Source: International Congress 2022 – Molecular footprints in lung cancer
Session: Molecular footprints in lung cancer
Session type: Thematic Poster
Number: 4107
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Kwiecien (Warszawa, Poland), E. Rutkowska (Warszawa, Poland), A. Raniszewska (Warszawa, Poland), J. Bednarek (Warszawa, Poland), R. Sokolowski (Warszawa, Poland), P. Rzepecki (Warszawa, Poland), J. Domagala-Kulawik (Warszawa, Poland). Terminal effector Tregs in metastatic lymph nodes of lung cancer patients. 4107
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|